Skip to main content
Clinical Trials/NCT00333333
NCT00333333
Completed
Not Applicable

Mechanism of Thrombocytopenia in Small for Gestational Age Infants Versus Infants With Maternal Preeclampsia Exposure

Christiana Care Health Services1 site in 1 country30 target enrollmentJune 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Thrombocytopenia
Sponsor
Christiana Care Health Services
Enrollment
30
Locations
1
Primary Endpoint
To determine the mechanism of thrombocytopenia in small for gestational age infants versus infants with maternal preeclampsia exposure
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

This research project is studying the causes for low platelet levels in preterm infants. Platelets are a component of blood that helps with clotting. The purpose of this study is to determine whether the cause for low platelet levels is the same in infants who are born to mothers with preeclampsia and infants who are small for gestational age.

Detailed Description

Thrombocytopenia is a common entity in infants who are born to mothers with preeclampsia and in infants who are small for gestational age. There have been several theories to the mechanism underlying thrombocytopenia in these groups of patients. One mechanism suggests that thrombocytopenia in these populations may be secondary to underproduction of platelets. Other studies have implied that low platelet levels may be due to endothelial activation causing platelet consumption. This study is being performed to help determine the mechanism causing thrombocytopenia in infants born to mothers with preeclampsia and comparing it to the mechanism of thrombocytopenia in infants who are small for gestational age.

Registry
clinicaltrials.gov
Start Date
June 2006
End Date
June 2008
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Infants who are less than 34 weeks gestation
  • Infants born to mothers with preeclampsia
  • Infants who are born small for gestational age whose mother did not have preeclampsia

Exclusion Criteria

  • Infants who are greater than 34 weeks gestation
  • Infants with known congenital anomalies or known congenital infections

Outcomes

Primary Outcomes

To determine the mechanism of thrombocytopenia in small for gestational age infants versus infants with maternal preeclampsia exposure

Time Frame: Each infant will only be enrolled during the time of birth until cord blood is collected.

Study Sites (1)

Loading locations...

Similar Trials